Breaking News
Sort by:
Top Post
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial for the Treatment of Rett Syndrome
Taysha Gene Therapies, a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene […]
Moderna Announces Bivalent Booster mRNA -1273.214 Demonstrates Potent Neutralizing Antibody Response Against Omicron Subvariants Ba.4 and Ba.5
Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Treatment With Hepcludex® (Bulevirtide) Meets Primary Endpoint and Achieves Significant Response in Chronic Hepatitis Delta Virus at 48 Weeks
Gilead Sciences, Inc. (Nasdaq: GILD) today announced Week 48 results from the Pivotal Phase 3 […]
Targovax Announces That the FDA Has Granted Authorization to Initiate Clinical Trials With the Enhanced TG01 RAS Vaccine in the USA
Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid […]
Naobios Delivers Flugen Inc’s M2SR Influenza Vaccine Candidate for Upcoming Clinical Trials
Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of […]
Aidoc Raises $110M to Address the Increasing Challenges Facing Health Systems by Using Artificial Intelligence
Aidoc, the leading provider of healthcare AI solutions, announced today a $110 million Series D round investment, […]
Endo Tools Therapeutics Receives Positive Opinion From French High Authority for Health on Forfait Innovation Scheme to Treat Patients With Diabetes
Endo Tools Therapeutics (ETT), a company developing advanced endoscopic medical devices, today announces that HAS, […]
H1 Secures an Extension on Its Series C to Further Its Mission of Creating a Healthier Future Through the Use of Connected and Accessible Healthcare Data
H1, the connecting force for global healthcare professional, clinical, science, and research information, announced today […]
Novavax Initiates Phase 3 Trial of its COVID-19 Omicron Strain Vaccine as a Booster
Novavax today announced the initiation of its Phase 3 strain change trial to determine if […]
GSK to Acquire Clinical-stage Biopharmaceutical Company Affinivax, Inc.
GSK plc (LSE/NYSE: GSK) today announced that it has entered into a definitive agreement to […]
IASO Biotherapeutics' Equecabtagene Autoleucel, the World's First CAR-T for Treatment of NMOSD, Receives IND Application Acceptance by NMPA
IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more